ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,139.83
0.75%
Dow Jones
38,239.66
0.40%
Gold vs US Dollar
2,337.935
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,073.78
-1.04%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Fusion Antibodies Plc (FAB)

  7. Fusion Antibodies Plc (FAB) News

Fusion Antibodies (FAB)

Fusion Antibodies Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FAB
DateTimeSourceHeadlineSymbolCompany
16/04/202407:00RNS Regulatory NewsFusion Antibodies PLC Change of auditorLSE:FABFusion Antibodies Plc
15/04/202413:29Alliance NewsAlliance NewsFusion Antibodies inks commercial contract for OptiPhage libraryLSE:FABFusion Antibodies Plc
15/04/202407:00RNS Regulatory NewsFusion Antibodies PLC Contract to develop a bespoke OptiPhage libraryLSE:FABFusion Antibodies Plc
02/04/202414:34RNS Regulatory NewsFusion Antibodies PLC Block admission six monthly returnLSE:FABFusion Antibodies Plc
28/03/202417:00RNS Regulatory NewsFusion Antibodies PLC Total Voting RightsLSE:FABFusion Antibodies Plc
11/03/202415:04RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
11/03/202409:10RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
08/03/202415:09RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
05/03/202410:40RNS Regulatory NewsFusion Antibodies PLC Result of General Meeting and Total Voting RightsLSE:FABFusion Antibodies Plc
29/02/202417:00RNS Regulatory NewsFusion Antibodies PLC Total Voting RightsLSE:FABFusion Antibodies Plc
27/02/202414:18Alliance NewsAlliance NewsTRADING UPDATES: Sondrel wins USD23 million contractLSE:FABFusion Antibodies Plc
27/02/202407:00RNS Regulatory NewsFusion Antibodies PLC First purchase order under MSALSE:FABFusion Antibodies Plc
14/02/202411:27Alliance NewsAlliance NewsIN BRIEF: Fusion Antibodies raises GBP1.4 million via placingLSE:FABFusion Antibodies Plc
14/02/202407:15RNS Regulatory NewsFusion Antibodies PLC Grant of options and issue of shares to directorsLSE:FABFusion Antibodies Plc
14/02/202407:00RNS Regulatory NewsFusion Antibodies PLC Placing to raise £1,375,000LSE:FABFusion Antibodies Plc
06/02/202411:48Alliance NewsAlliance NewsFusion Antibodies strikes follow-on research and development projectLSE:FABFusion Antibodies Plc
06/02/202407:00RNS Regulatory NewsFusion Antibodies PLC Follow-on project award and R&D updateLSE:FABFusion Antibodies Plc
01/02/202412:00Alliance NewsAlliance NewsFusion Antibodies gets tax credit from UK HMRC for OptiMAL platformLSE:FABFusion Antibodies Plc
01/02/202407:00RNS Regulatory NewsFusion Antibodies PLC HMRC R&D tax creditLSE:FABFusion Antibodies Plc
04/12/202312:26UK RegulatoryFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
04/12/202310:22Alliance NewsAlliance NewsFusion Antibodies shares fall with revenue despite "positive" outlookLSE:FABFusion Antibodies Plc
04/12/202307:00UK RegulatoryFusion Antibodies PLC Half-year ReportLSE:FABFusion Antibodies Plc
28/11/202313:23Dow Jones NewsFusion Antibodies Shares Rise on US Cancer Institute CollaborationLSE:FABFusion Antibodies Plc
28/11/202312:09Alliance NewsAlliance NewsFusion Antibodies shares up on deal with US National Cancer InstituteLSE:FABFusion Antibodies Plc
28/11/202307:00UK RegulatoryFusion Antibodies PLC OptiMAL collaboration agreementLSE:FABFusion Antibodies Plc
09/11/202312:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Wincanton profit down; James Cropper ups payoutLSE:FABFusion Antibodies Plc
09/11/202307:00UK RegulatoryFusion Antibodies PLC Half year trading updateLSE:FABFusion Antibodies Plc
27/10/202311:57UK RegulatoryFusion Antibodies PLC Result of AGMLSE:FABFusion Antibodies Plc
04/10/202314:45UK RegulatoryFusion Antibodies PLC Block admission six monthly returnLSE:FABFusion Antibodies Plc
29/09/202321:19Alliance NewsAlliance NewsEARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widensLSE:FABFusion Antibodies Plc
 Showing the most relevant articles for your search:LSE:FAB

Your Recent History

LSE
BIRD
Blackbird
LSE
ITM
Itm Power
LSE
GOLD
LSE
SCLP
Scancell
LSE
GGP
Greatland Gold
LSE
AAZ
Anglo Asian Mining
LSE
POS
Plexus
LSE
AAU
Ariana Resources
LSE
SOLG
Solgold
LSE
AGL
Angle
LSE
LLOY
Lloyds Banking
LSE
HUM
Hummingbird Resources
LSE
TPL
Tethys
LSE
LGEN
Legal & General
LSE
ENET
Ethernity Networks
LSE
I3E
I3 Energy
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved